Published in Psychopharmacology (Berl) on July 27, 2010
Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology (2013) 0.94
Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum. Nicotine Tob Res (2014) 0.80
SLCO3A1, A novel crohn's disease-associated gene, regulates nf-κB activity and associates with intestinal perforation. PLoS One (2014) 0.75
Cocaine-induced Psychosis and Brain-derived Neurothrophic Factor in Patients with Cocaine Dependence: Report of Two Cases. Clin Psychopharmacol Neurosci (2016) 0.75
A Lack of Correlation between Brain-Derived Neurotrophic Factor Serum Level and Verbal Memory Performance in Healthy Polish Population. Front Neural Circuits (2016) 0.75
Neurotrophin levels at admission did not change significantly upon alcohol deprivation and were positively correlated with the BMI and LDL levels. J Mol Psychiatry (2013) 0.75
Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet (2010) 6.68
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res (2005) 5.78
Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature (1997) 4.01
Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict (2005) 3.89
Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology (1998) 2.89
Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett (2002) 2.51
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 2.28
Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry (1998) 1.95
Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev (2005) 1.93
RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci (2004) 1.55
Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet (2005) 1.55
Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology (2003) 1.48
Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res (1985) 1.47
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front Biosci (2008) 1.38
Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res (1996) 1.37
The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry (2002) 1.34
Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci (1995) 1.31
Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+/-) mice. J Neurochem (2003) 1.31
Why do patients with schizophrenia smoke? Curr Opin Psychiatry (2010) 1.25
The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol (2005) 1.24
Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience (2003) 1.18
Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res (2002) 1.13
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res (2008) 1.07
Brain derived neurotropic factor in first-episode psychosis. Schizophr Res (2007) 1.07
Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res (2005) 1.06
Smoking, Genetics and Schizophrenia: Evidence for Self Medication. J Dual Diagn (2007) 1.04
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry (2010) 1.03
Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res (2010) 1.02
Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) (2009) 1.02
Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci Lett (2007) 1.02
Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res (2006) 1.02
Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett (2003) 1.01
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res (2006) 1.01
Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.00
Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor. Brain Res (2006) 0.99
Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett (2004) 0.99
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett (2008) 0.99
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett (2007) 0.98
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem (1998) 0.97
High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett (2005) 0.96
Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.96
Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett (2005) 0.96
Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.95
Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.95
A critique of the dopamine hypothesis of schizophrenia and psychosis. Harv Rev Psychiatry (2009) 0.95
Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J Psychiatr Res (2006) 0.94
Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci Lett (2009) 0.94
Nicotinic acetylcholine receptor system and neuropsychiatric disorders. IDrugs (2004) 0.90
The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry (2008) 0.89
Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse (2000) 0.88
Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophr Res (2006) 0.88
The BDNF Val66Met polymorphism and smoking. Neurosci Lett (2008) 0.87
Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry (2004) 0.86
Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Hum Psychopharmacol (2010) 0.86
Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun (2005) 0.85
Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clin Neuropharmacol (1987) 0.84
Sex difference in the prevalence of smoking in Chinese schizophrenia. J Psychiatr Res (2010) 0.84
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J Neural Transm (Vienna) (1997) 0.82
Chronic neonatal nicotine exposure increases mRNA expression of neurotrophic factors in the postnatal rat hippocampus. Brain Res (2009) 0.82
Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice. Synapse (2009) 0.79
Brain-derived neurotrophic factor (BDNF) and TrkB in the piglet brainstem after post-natal nicotine and intermittent hypercapnic hypoxia. Brain Res (2008) 0.78
Nicotine affects the expression of brain-derived neurotrophic factor mRNA and protein in the hippocampus of hypoxic newborn piglets. J Perinat Med (2009) 0.76
The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) (2002) 9.90
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med (2007) 5.68
A memory retrieval-extinction procedure to prevent drug craving and relapse. Science (2012) 4.04
Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry (2009) 3.61
Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci (2003) 3.30
The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr (2010) 2.61
Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med (2006) 2.37
Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res (2005) 2.34
Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol (2005) 2.32
Indoor air pollution and blood pressure in adult women living in rural China. Environ Health Perspect (2011) 2.25
A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci (2004) 2.23
Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry (2005) 2.18
Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology (2002) 2.08
VIDEOS IN CLINICAL MEDICINE. Examination of the Retina. N Engl J Med (2015) 1.99
Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell (2012) 1.94
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry (2005) 1.82
Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology (2005) 1.79
Substance abuse vaccines. Ann N Y Acad Sci (2008) 1.74
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood (2013) 1.73
Extensive primary repair of the thoracic aorta in acute type a aortic dissection by means of ascending aorta replacement combined with open placement of triple-branched stent graft: early results. Circulation (2010) 1.73
HIV and STIs in clients and female sex workers in mining regions of Gejiu City, China. Sex Transm Dis (2008) 1.72
Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol (2009) 1.72
Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat (2004) 1.70
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry (2006) 1.66
Rare ADH variant constellations are specific for alcohol dependence. Alcohol Alcohol (2012) 1.66
Prescription pain medication dependence. Am J Psychiatry (2011) 1.65
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients. Cardiology (2012) 1.59
Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med (2006) 1.58
Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.54
Effects of stress on decision-making deficits in formerly heroin-dependent patients after different durations of abstinence. Am J Psychiatry (2011) 1.50
A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol Abuse (2009) 1.49
Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother (2009) 1.45
Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) (2006) 1.44
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis (2008) 1.43
Oxidized Low-Density Lipoprotein Promotes Macrophage Lipid Accumulation via the Toll-Like Receptor 4-Src Pathway. Circ J (2015) 1.42
Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci (2011) 1.40
Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci (2008) 1.39
Relationship between full-thickness macular hole and retinal break/lattice degeneration. Eye Sci (2015) 1.39
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol (2008) 1.35
Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol Psychiatry (2005) 1.35
Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev (2009) 1.31
Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict (2004) 1.29
Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend (2004) 1.28
Stress effects in the hippocampus: synaptic plasticity and memory. Stress (2006) 1.28
Therapeutic vaccines for substance dependence. Expert Rev Vaccines (2004) 1.27
Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) (2005) 1.26
Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav (2004) 1.26
Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.26
MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett (2011) 1.25
Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol (2006) 1.25
Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse (2003) 1.23
Vaccines for cocaine abuse. Hum Vaccin (2009) 1.23
Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health (2010) 1.23
Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. Am J Drug Alcohol Abuse (2007) 1.21
Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs (2006) 1.20
Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood (2013) 1.20
A novel, functional and replicable risk gene region for alcohol dependence identified by genome-wide association study. PLoS One (2011) 1.19
Spatiotemporal transmission and determinants of typhoid and paratyphoid fever in Hongta District, Yunnan Province, China. PLoS Negl Trop Dis (2013) 1.19
Stress impairs reconsolidation of drug memory via glucocorticoid receptors in the basolateral amygdala. J Neurosci (2008) 1.19
Novel approaches to the treatment of cocaine addiction. CNS Drugs (2005) 1.18
PKMζ maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex. Neuropsychopharmacology (2011) 1.16
Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry (2002) 1.16
Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neurosci Lett (2009) 1.16
Basolateral amygdala cdk5 activity mediates consolidation and reconsolidation of memories for cocaine cues. J Neurosci (2010) 1.16
Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry (2010) 1.15
Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS One (2013) 1.15
eBLOCKs: enumerating conserved protein blocks to achieve maximal sensitivity and specificity. Nucleic Acids Res (2005) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
[Male circumcision is an effective "surgical vaccine" for HIV prevention and reproductive health]. Zhonghua Nan Ke Xue (2009) 1.14
Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry (2004) 1.13
Recent trends in drug abuse in China. Acta Pharmacol Sin (2006) 1.13
Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One (2012) 1.13
Screening for significant atherosclerotic renal artery stenosis with a regression model in patients undergoing transradial coronary angiography/intervention. J Zhejiang Univ Sci B (2012) 1.13
Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology (2005) 1.13
Identification of 3 distinct HIV-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 Chinese cities. J Acquir Immune Defic Syndr (2013) 1.13
Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement. Cell Mol Neurobiol (2007) 1.12
Emerging variability in HIV-1 genetics among recently infected individuals in Yunnan, China. PLoS One (2013) 1.12
Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes. Harm Reduct J (2008) 1.12
Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats. Behav Brain Res (2007) 1.11
Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 1.11
The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep (2007) 1.11
Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med (2011) 1.10
Prospective cohort study of HIV incidence and molecular characteristics of HIV among men who have sex with men(MSM) in Yunnan Province, China. BMC Infect Dis (2013) 1.09
Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacol Biochem Behav (2007) 1.09
Scalp acupuncture for acute ischemic stroke: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med (2012) 1.09
Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse (2009) 1.09
Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother (2004) 1.09
Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers. Pharmacol Biochem Behav (2007) 1.08
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend (2010) 1.08
Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2010) 1.08
Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion. PLoS One (2012) 1.08
Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2013) 1.08
A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. J Neurochem (2011) 1.08
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res (2005) 1.07
Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res (2009) 1.06
Predicting the protein SUMO modification sites based on Properties Sequential Forward Selection (PSFS). Biochem Biophys Res Commun (2007) 1.06